Last reviewed 2026-04-23 · How we verify

Shortened duration of antifungal therapy

Assistance Publique - Hôpitaux de Paris · Phase 3 active Small molecule

Shortened duration of antifungal therapy is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 3 development for Treatment of fungal infections.

Shortened duration of antifungal therapy is achieved by reducing the time required to treat fungal infections.

Shortened duration of antifungal therapy is achieved by reducing the time required to treat fungal infections. Used for Treatment of fungal infections.

At a glance

Generic name	Shortened duration of antifungal therapy
Sponsor	Assistance Publique - Hôpitaux de Paris
Modality	Small molecule
Therapeutic area	Infectious Diseases
Phase	Phase 3

Mechanism of action

This is done by using a more potent antifungal agent or by optimizing the treatment regimen to minimize the duration of therapy. As a result, patients can recover faster and with fewer side effects.

Approved indications

Treatment of fungal infections

Common side effects

Nausea
Diarrhea
Abdominal pain

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Shortened duration of antifungal therapy CI brief — competitive landscape report
Shortened duration of antifungal therapy updates RSS · CI watch RSS
Assistance Publique - Hôpitaux de Paris portfolio CI

Frequently asked questions about Shortened duration of antifungal therapy

What is Shortened duration of antifungal therapy?

Shortened duration of antifungal therapy is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris, indicated for Treatment of fungal infections.

How does Shortened duration of antifungal therapy work?

Shortened duration of antifungal therapy is achieved by reducing the time required to treat fungal infections.

What is Shortened duration of antifungal therapy used for?

Shortened duration of antifungal therapy is indicated for Treatment of fungal infections.

Who makes Shortened duration of antifungal therapy?

Shortened duration of antifungal therapy is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).

What development phase is Shortened duration of antifungal therapy in?

Shortened duration of antifungal therapy is in Phase 3.

What are the side effects of Shortened duration of antifungal therapy?

Common side effects of Shortened duration of antifungal therapy include Nausea, Diarrhea, Abdominal pain.

Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
Therapeutic area: All drugs in Infectious Diseases
Indication: Drugs for Treatment of fungal infections
Compare: Shortened duration of antifungal therapy vs similar drugs
Pricing: Shortened duration of antifungal therapy cost, discount & access